BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23422242)

  • 1. The effect of androgens on lipids.
    Monroe AK; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):132-9. PubMed ID: 23422242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.
    Bell RJ; Davison SL; Papalia MA; McKenzie DP; Davis SR
    Menopause; 2007; 14(4):630-8. PubMed ID: 17224854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
    Tripathy D; Shah P; Lakshmy R; Reddy KS
    Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular issues in hypogonadism and testosterone therapy.
    Shabsigh R; Katz M; Yan G; Makhsida N
    Am J Cardiol; 2005 Dec; 96(12B):67M-72M. PubMed ID: 16387571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
    Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women.
    Worsley R; Robinson PJ; Bell RJ; Moufarege A; Davis SR
    Menopause; 2013 Jun; 20(6):640-5. PubMed ID: 23531683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men.
    Jockenhövel F; Bullmann C; Schubert M; Vogel E; Reinhardt W; Reinwein D; Müller-Wieland D; Krone W
    Metabolism; 1999 May; 48(5):590-6. PubMed ID: 10337859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study.
    Khatibi A; Agardh CD; Shakir YA; Nerbrand C; Nyberg P; Lidfeldt J; Samsioe G
    Climacteric; 2007 Oct; 10(5):386-92. PubMed ID: 17852141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC; Shiu SW; Pang RW; Kung AW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on lipoprotein profile after long-term testosterone replacement in hypogonadal men.
    Berg G; Schreier L; Geloso G; Otero P; Nagelberg A; Levalle O
    Horm Metab Res; 2002 Feb; 34(2):87-92. PubMed ID: 11972293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis.
    Whitsel EA; Boyko EJ; Matsumoto AM; Anawalt BD; Siscovick DS
    Am J Med; 2001 Sep; 111(4):261-9. PubMed ID: 11566455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male.
    Schleich F; Legros JJ
    Eur J Endocrinol; 2004 Oct; 151(4):415-24. PubMed ID: 15476438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
    Agledahl I; Skjaerpe PA; Hansen JB; Svartberg J
    Nutr Metab Cardiovasc Dis; 2008 May; 18(4):256-62. PubMed ID: 17560771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone health in hypogonadal men.
    Irwig MS
    Curr Opin Urol; 2014 Nov; 24(6):608-13. PubMed ID: 25144148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile of women with premature ovarian failure.
    Knauff EA; Westerveld HE; Goverde AJ; Eijkemans MJ; Valkenburg O; van Santbrink EJ; Fauser BC; van der Schouw YT
    Menopause; 2008; 15(5):919-23. PubMed ID: 18551082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypogonadism and cardiovascular diseases in men].
    Ter Arkh; 2011; 83(10):61-7. PubMed ID: 22185029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.